• All
  • Article Title
  • Abstract
  • Keywords
  • Author
  • Institution
  • Open Access
    Review

    A narrative review on the role of gut microbiome, dietary strategies, and supplements in managing metabolic syndrome

    Sunil Chopra 1
    Vandana Dahiya 2
    Anu Saini 3
    Ramendra Pati Pandey 4*

    Explor Drug Sci. 2025;3:1008105 DOI: https://doi.org/10.37349/eds.2025.1008105

    Received: January 16, 2025 Accepted: April 01, 2025 Published: April 14, 2025

    Academic Editor: Marcello Iriti, Milan State University, Italy

    This article belongs to the special issue Preventive and Therapeutic Potential of Nutraceuticals in Non-communicable Diseases

    Abstract

    Metabolic syndrome is a complex, multifactorial disorder, with emerging research emphasizing the significant role of gut health in its prevention and management. Recent studies suggest that dietary strategies promoting a healthy gut microbiome, including the incorporation of fiber, fermented foods, and healthy fats, are crucial for regulating metabolism. Additionally, the use of postbiotics and supplements, such as probiotics, omega-3 fatty acids, and polyphenols, provides promising avenues for enhancing metabolic health. This holistic approach to managing metabolic syndrome not only supports gut health but also offers the potential for improving long-term health outcomes. This review examines the influence of the gut microbiome on metabolism, highlighting the increasing significance of dietary strategies and supplements in managing metabolic syndrome.

    Keywords

    Metabolic syndrome, healthy gut microbiome, probiotics, omega-3 fatty acid, dietary strategies

    Introduction

    Metabolic syndrome, a cluster of risk factors for cardiovascular diseases, diabetes, and obesity, has become one of the leading global health challenges of the 21st century. Defined by a combination of abdominal obesity, hypertension, dyslipidemia, and insulin resistance, this condition affects millions worldwide and has a profound impact on healthcare systems and individuals’ well-being. As a multifactorial disorder, the treatment and management of metabolic syndrome require a comprehensive, integrated approach that goes beyond traditional pharmaceutical interventions [13].

    Recent research has highlighted the critical role of the gut microbiome in influencing metabolic health. The gut microbiome, comprising trillions of microorganisms residing in the digestive tract, plays a crucial role in the digestion of food, regulation of metabolism, immune function, and even mental health. A growing body of evidence suggests that the composition of the gut microbiome plays a pivotal role in the development and progression of metabolic syndrome. Consequently, dietary strategies that promote a healthy gut microbiome, using postbiotics, and incorporating innovative supplements are emerging as key interventions for managing and potentially reversing metabolic syndrome [46].

    Therefore, this study aims to investigate the role of the gut microbiota (GM) in the prevention and management of metabolic syndrome. It focuses on the effects of dietary strategies and supplements, such as fiber, fermented foods, healthy fats, probiotics, postbiotics, omega-3 fatty acids, and polyphenols, on regulating metabolism and enhancing long-term metabolic health outcomes.

    The role of the gut microbiome in metabolic syndrome

    The regulation of metabolic syndrome, which includes insulin resistance, obesity, and dyslipidemia, is greatly influenced by the gut microbiome [7]. Increased energy extraction and changed fat storage are two effects of dysbiosis, whereas insulin resistance impacts vascular tone and insulin sensitivity. It also has an impact on bile acid synthesis and lipid metabolism, resulting in lower HDL cholesterol levels and higher LDL cholesterol levels. An unbalanced microbiome can exacerbate metabolic syndrome and inflammation by causing endotoxemia [8]. The gut-brain axis influences hormones that regulate appetite, and beneficial gut bacteria produce short-chain fatty acids (SCFAs) that modulate insulin sensitivity and glucose metabolism. A balanced immune response and better metabolic profiles are supported by a varied microbiome [9, 10]. There are various aspects of metabolic syndrome, as shown in Figure 1.

    Various aspects of metabolic syndrome. SCFAs: short-chain fatty acids; NAFLD: non-alcoholic fatty liver disease

    The gut microbiome plays a crucial role in digesting complex carbohydrates, producing SCFAs, and regulating various metabolic pathways. Studies have shown that individuals with metabolic syndrome tend to have an altered gut microbiome characterized by lower microbial diversity and an overabundance of harmful bacteria. This dysbiosis contributes to systemic inflammation, insulin resistance, and disturbances in lipid metabolism—key features of metabolic syndrome [11, 12].

    A contributing factor to the rise in non-alcoholic fatty liver disease (NAFLD) worldwide is GM. By increasing permeability, dysbiosis exposes the liver to bacteria and their byproducts. Although the exact pathogenic processes of GM in NAFLD are unknown, gut dysbiosis seems to be linked to its development. The pathophysiology of NAFLD, a common chronic liver disease, is significantly influenced by dysbiosis of the GM. According to European clinical recommendations, only 40% of people can lose weight and improve their lifestyle [13]. Though further research is required to generalize these findings, new therapy techniques, such as GM modification-based medicines like probiotics synbiotics, have demonstrated encouraging benefits in animal experiments [14]. In patients with metabolic dysfunction associated with steatotic liver disease (MASLD), the study found a nonlinear association between the neutrophil percentage-to-albumin ratio, the neutrophil-to-lymphocyte ratio, and the systemic immune-inflammation index (SII) with all-cause and cardiovascular disease mortality. However, after controlling for relevant factors, there was no significant correlation between the SII and mortality [15].

    SCFAs, including butyrate, acetate, and propionate, are produced by gut bacteria during the fermentation of dietary fiber. These SCFAs have numerous beneficial effects on metabolic health, including enhancing insulin sensitivity, reducing inflammation, and improving lipid profiles. Furthermore, SCFAs act as signaling molecules, influencing gene expression in the gut and other organs [7, 16]. A healthy gut microbiome, rich in fiber-fermenting bacteria, helps maintain optimal SCFA production, supporting metabolic processes crucial for preventing and managing metabolic syndrome through various mechanisms, as outlined in Table 1.

    Role of gut microbiome and their mode of action against various metabolic syndromes

    Aspect of metabolic syndromeRole of the gut microbiota (GM)Mechanisms of actionReferences
    ObesityGM composition is linked to obesity riskDysbiosis (imbalance of GM) may lead to increased energy extraction from food and altered fat storage. Certain bacteria, such as those belonging to the Firmicutes group, are associated with a higher energy harvest from food, which contributes to weight gain.Alou et al. [17], 2016; Amabebe et al. [18], 2020
    Insulin resistanceGM affects insulin sensitivityThe altered gut microbiome can influence insulin resistance by increasing inflammation, producing metabolites such as short-chain fatty acids (SCFAs) that improve insulin function, or modifying bile acid metabolism.Saad et al. [19], 2016; Visekruna and Luu [20], 2021
    High blood pressureGM may influence blood pressure regulationAn imbalance in GM can lead to an increased production of endotoxins, which promote inflammation and hypertension. Gut-produced SCFAs can help regulate blood pressure by affecting vascular tone and sodium balance.Mozaffarian and Wu [21], 2018
    DyslipidemiaMicrobiota affects lipid metabolismGut bacteria can influence lipid metabolism, bile acid synthesis, and the absorption of fat. Dysbiosis can lead to elevated levels of LDL cholesterol, triglycerides, and reduced HDL cholesterol. Beneficial bacteria, such as Lactobacillus and Bifidobacterium, may help improve lipid profiles.Schoeler and Caesar [22], 2019; Wang et al. [23], 2019; Zarezadeh et al. [24], 2023
    InflammationDysbiosis promotes chronic low-grade inflammationAn imbalance in GM increases gut permeability (“leaky gut”), allowing endotoxins to enter the bloodstream and trigger systemic inflammation. This inflammation contributes to metabolic dysfunction and the development of metabolic syndrome.Candelli et al. [25], 2021
    NAFLDGM plays a role in liver healthThe gut microbiome can influence liver fat accumulation and inflammation. Dysbiosis may contribute to the development of fatty liver disease by increasing intestinal permeability and triggering an inflammatory response in the liver.Saltzman et al. [26], 2018; Yaghmaei et al. [14], 2024
    EndotoxemiaGM contributes to endotoxin productionAn imbalanced gut microbiome, especially with an overgrowth of gram-negative bacteria, can lead to the production of lipopolysaccharides (LPS), which are pro-inflammatory and contribute to the development of metabolic syndrome.Çakirlar [27], 2025
    Gut-brain axisThe gut microbiome influences appetite and metabolism through the gut-brain axisGM affects the release of appetite-regulating hormones such as ghrelin and leptin, influencing hunger and satiety signals. Altered microbiota can disrupt these signals, contributing to overeating and obesity.Han et al. [28], 2021; Smitka et al. [29], 2021
    SCFAsSCFAs produced by GM are beneficial for metabolic healthSCFAs (e.g., acetate, propionate, butyrate) help regulate glucose metabolism, reduce inflammation, and improve insulin sensitivity. SCFAs are produced by the fermentation of dietary fibers by beneficial gut bacteria.Koh et al. [30], 2016; Portincasa et al. [31], 2022
    Bile acid metabolismThe gut microbiome plays a crucial role in regulating bile acid metabolismGut bacteria modify bile acids, which in turn influence fat digestion and absorption. Altered bile acid metabolism can affect lipid metabolism, insulin sensitivity, and the development of metabolic diseases.Chávez-Talavera et al. [32], 2017; Ramirez-Pérez et al. [33], 2017
    Microbial diversityGreater microbial diversity is associated with better metabolic healthHigher microbial diversity is associated with a healthier metabolic profile, improved immune function, and reduced inflammation. Low diversity is often associated with obesity, insulin resistance, and dyslipidemia.Aron-Wisnewsky et al. [34], 2021; Vallianou et al. [35], 2019
    Display full size

    NAFLD: non-alcoholic fatty liver disease

    Dietary strategies to enhance gut microbiome health

    A well-balanced diet is essential for supporting gut health and general well-being. Increasing fiber intake from fruits, vegetables, and whole grains enhances digestion and promotes a balanced gut microbiome. Prebiotics support healthy gut flora and are found in foods such as garlic, onions, and bananas. Yogurt, kefir, and kimchi are examples of fermented foods that contain probiotics that improve intestinal health. Berries, green tea, and dark chocolate are examples of foods high in polyphenols that can help prevent inflammation and oxidative stress [36, 37]. The anti-inflammatory properties of omega-3 fatty acids, which can be found in foods such as walnuts, chia seeds, and fish, are beneficial for the heart and brain [38]. It is crucial to cut back on processed foods and added sugars to prevent affecting metabolism and gut health [39]. Eating more plant-based foods, such as legumes, nuts, and leafy greens, and limiting animal protein and fat can promote improved digestion and lower the risk of developing chronic illnesses [40]. A prebiotic and blood sugar regulator, resistant starch is found in foods such as potatoes, rice, and oats [41]. For proper digestion and nutrition absorption, it is essential to stay hydrated by drinking lots of water. Because too much alcohol can harm the gut lining and upset the microbial balance, it is crucial to moderate your intake. Ultimately, consuming a varied diet rich in plant-based foods ensures a diverse range of nutrients and fosters a well-balanced gut microbiome [42, 43]. The dietary habits that impact GM health are shown in Figure 2.

    Dietary practices that affect the health of the gut microbiota

    Anti-inflammatory diets, as indicated by lower dietary inflammatory index (DII) scores, may be associated with variations in the microbiome, offering potential insights into microbiota research; however, further research is required [44]. According to the study, there is a negative link between the dietary index for GM (DI-GM) and the prevalence of metabolic dysfunction-associated fatty liver disease (MAFLD), with race having a major impact on this relationship. This suggests that dietary modifications may help prevent MAFLD and highlight racial disparities in intervention efforts [45]. Using the DII to measure gut microbiome diversity, composition, and function, another study investigated the relationship between dietary inflammatory potential and these variables. The results showed that while Akkermansia muciniphila was more common in the group that followed the most anti-inflammatory diet, certain microbes, such as Ruminococcus torques, Eubacterium nodatum, Acidaminococcus intestini, and Clostridium leptum, were more common in the group that followed the most pro-inflammatory diet. The study suggests that more research is needed with prospective cohorts and larger sample sizes [46]. According to research, consuming a more anti-inflammatory diet can help prevent ectopic fat deposition, maintain a healthy GM, reduce inflammation, and limit the accumulation of fat mass. To confirm these results, however, more extensive prospective research is required [47].

    A diet that supports gut health is essential for preventing and managing metabolic syndrome. Table 2 provides several dietary strategies that can enhance the gut microbiome, improve metabolic markers, and help mitigate the risk factors associated with metabolic syndrome.

    Outlines dietary strategies to improve gut health and metabolism

    Dietary strategyFood sourcesMechanisms of actionImpact on metabolic syndromeReferences
    Increase fiber intakeWhole grains (e.g., oats, quinoa), legumes (e.g., beans, lentils), fruits (e.g., apples, berries), vegetables (e.g., broccoli, spinach), nuts, seedsFiber serves as a prebiotic, feeding beneficial gut bacteria and promoting the production of SCFAs.It improves insulin sensitivity, supports weight management, and helps reduce inflammation—key factors in managing metabolic syndrome.Tannock and Liu [48], 2020; Vinelli et al. [49], 2022
    Incorporate prebioticsGarlic, onions, leeks, asparagus, bananas, chicory, artichokesPrebiotics stimulate the growth of beneficial gut bacteria, supporting microbial diversity and SCFA production.Enhances gut health, lowers inflammation, and supports better metabolic control.Fernández et al. [50], 2016; Peredo-Lovillo et al. [51], 2020
    Consume fermented foodsYogurt, kefir, sauerkraut, kimchi, miso, kombucha, picklesFermented foods contain probiotics that introduce beneficial bacteria to the gut, improving microbial balance and digestion.Enhances GM, boosts immunity, and may help lower cholesterol and blood pressure.Beena Divya et al. [52], 2012; Parvez et al. [53], 2006; Dimidi et al. [54], 2019; Dahiya and Nigam [55], 2022
    Polyphenol-rich foodsBerries, apples, dark chocolate, green tea, olive oil, red wine, nuts (e.g., almonds, walnuts)Polyphenols support the growth of beneficial bacteria and help reduce the growth of harmful bacteria, thereby promoting anti-inflammatory effects.Reduces oxidative stress, supports heart health, and improves lipid profiles, thereby reducing the risk of metabolic syndrome.Wang et al. [56], 2022
    Consume omega-3 fatty acidsFatty fish (e.g., salmon, mackerel), chia seeds, flaxseeds, walnutsOmega-3s promote the growth of anti-inflammatory gut bacteria and help regulate gut function.Reduces systemic inflammation, supports better lipid metabolism, and improves insulin sensitivity.Barbalho et al. [57], 2016
    Processed foods & added sugarsRefined sugars, sugary drinks, processed snacks, fast foodHigh consumption of processed foods and added sugars disrupts GM and promotes harmful bacteria, leading to inflammation and metabolic disturbances.Reduces the risk of obesity, insulin resistance, and dyslipidemia associated with metabolic syndrome.Garcia et al. [58], 2022; Miclotte and Van de Wiele [39], 2020
    Moderate animal protein & fatRed meat, processed meats, fatty cuts of meatExcessive animal protein and fat intake can lead to an imbalance in GM, promoting inflammation and metabolic dysfunction.Helps prevent weight gain, insulin resistance, and dyslipidemia by supporting a balanced gut microbiome.Zhao et al. [59], 2019; Ma et al. [60], 2017
    Increase plant-based foodsVegetables, fruits, whole grains, legumes, nuts, seedsPlant-based foods are rich in fiber, antioxidants, and polyphenols that nurture a diverse microbiome and enhance overall gut health.Supports weight management, improves insulin sensitivity, and reduces inflammation, all key to preventing metabolic syndrome.Bulsiewicz [61], 2020; Daniel et al. [62], 2023
    Include resistant starchCooked and cooled potatoes, pasta, rice, green bananas, legumesResistant starch feeds beneficial gut bacteria, enhancing SCFA production and gut health.Improves insulin sensitivity, supports healthy blood sugar levels, and aids in weight management.Regassa and Nyachoti [63], 2018; Keenan et al. [64], 2015
    Hydrate wellWater, herbal teas, soupsProper hydration supports digestion and gut motility, maintaining GM balance.Promotes healthy digestion, enhances nutrient absorption, and helps regulate metabolic processes.Mach and Fuster-Botella [65], 2017; Zhang et al. [66], 2021
    Avoid excessive alcoholN/A (moderation or avoidance of alcohol)Excessive alcohol disrupts GM and increases gut permeability, leading to inflammation and metabolic disturbances.Reduces risk of liver disease, insulin resistance, and inflammation associated with metabolic syndrome.Bishehsari et al. [67], 2017; Bajaj [68], 2019
    Diverse dietA variety of fruits, vegetables, whole grains, legumes, nuts, seeds, and lean proteinsA diverse diet promotes the growth of a diverse microbiome, which is linked to better overall health and metabolic function.Enhances metabolic flexibility, reduces inflammation, and supports weight management, all crucial for managing metabolic syndrome.Hills et al. [69], 2019; Ross et al. [70], 2024
    Use bone brothBone broth, collagen-rich foodsBone broth supports gut barrier integrity and reduces gut permeability, helping maintain a healthy microbiome.Supports gut health and immune function, improving overall metabolic markers.Cooney et al. [71], 2021; Skinner [72], 2017
    Display full size

    GM: gut microbiota; SCFAs: short-chain fatty acids

    Increase fiber intake

    Dietary fiber, particularly prebiotics, serves as food for beneficial gut bacteria. The microbiota ferments prebiotic fibers in fruits, vegetables, whole grains, legumes, and certain tubers to produce SCFAs. High-fiber diets promote a healthy microbiome composition and have been shown to improve insulin sensitivity, reduce inflammation, and lower blood cholesterol levels. Foods rich in soluble fiber, such as oats, barley, and legumes, are particularly effective in modulating blood sugar and cholesterol levels, key components of metabolic syndrome [73, 74].

    Incorporate fermented foods

    Fermented foods, such as yogurt, kefir, kimchi, sauerkraut, and miso, are rich in probiotics—live microorganisms that confer health benefits when consumed in adequate amounts. Probiotics have been shown to improve gut microbiome diversity and modulate the immune system, which can help alleviate the systemic inflammation associated with metabolic syndrome. Regular consumption of fermented foods may help restore a healthy gut microbiome, enhance SCFA production, and improve insulin sensitivity, which is crucial for preventing and managing metabolic syndrome [7577].

    Reduce intake of processed foods and sugars

    Processed foods, mainly those high in refined sugars and unhealthy fats, contribute to gut dysbiosis and inflammation. High-sugar diets promote the growth of pathogenic bacteria and fungi in the gut, leading to an imbalance that exacerbates insulin resistance and metabolic dysfunction. Reducing the intake of processed foods, sugary beverages, and trans fats can help restore gut health and improve metabolic parameters. Instead, a diet rich in whole, unprocessed foods—especially plant-based—supports a more diverse and beneficial microbiome [78, 79].

    Increase healthy fats

    Monounsaturated and polyunsaturated fats in foods such as olive oil, avocados, fatty fish, and nuts have anti-inflammatory properties that can improve metabolic health. These healthy fats help modulate the gut microbiome, supporting beneficial bacteria growth while reducing harmful bacteria's proliferation. Omega-3 fatty acids, in particular, have been shown to improve insulin sensitivity and reduce inflammation, which are key factors in managing metabolic syndrome [80].

    Postbiotics and their role in metabolic health

    While probiotics are live microorganisms that confer health benefits, postbiotics are the bioactive compounds produced by probiotics during fermentation. These include SCFAs, peptides, enzymes, and other metabolites that positively impact health. Postbiotics are gaining attention for their potential therapeutic applications in managing metabolic syndrome.

    Research has shown that postbiotics derived from fermented foods and probiotics can enhance insulin sensitivity, reduce inflammation, and support the gut barrier function. Butyrate, one of the most studied postbiotics, has been shown to have potent anti-inflammatory and insulin-sensitizing effects. Butyrate, produced by the fermentation of fiber, helps regulate the expression of genes involved in glucose metabolism and fatty acid oxidation. By increasing butyrate production, individuals with metabolic syndrome can potentially experience improvements in their metabolic health [81, 82].

    In addition to butyrate, other postbiotics such as lactate, propionate, and acetate also play crucial roles in regulating metabolism. These metabolites help regulate the immune response, improve gut barrier integrity, and modulate lipid metabolism, all essential for managing metabolic syndrome [83].

    Innovative supplements for metabolic syndrome

    Probiotics, berberine, and curcumin are among the supplements that are becoming more and more well-liked due to their possible advantages in controlling metabolic health. Probiotics, such as Bifidobacterium and Lactobacillus, help balance the GM, increase insulin sensitivity, and lower inflammation, all of which contribute to weight management. AMP-activated protein kinase (AMPK) is triggered by berberine, which is obtained from Berberis species [84, 85]. This improves blood sugar and lipid profiles by enhancing glucose metabolism and lipid control. Turmeric’s main ingredient, curcumin, decreases oxidative stress, has strong anti-inflammatory properties, and supports metabolic pathways related to fat metabolism and insulin resistance [86]. Omega-3 fatty acids from fish or algae oil improve lipid profiles, lower inflammation, and strengthen the heart [87]. Known for its antioxidant qualities, alpha-lipoic acid (ALA) promotes weight management, lowers oxidative stress, and improves glucose absorption. By improving glucose absorption, cinnamon extract’s polyphenols reduce inflammation, lower blood sugar, and increase insulin sensitivity [88]. Chromium picolinate helps to normalize blood sugar levels and improves the action of insulin. Magnesium helps endothelial function, controls glucose metabolism, and enhances insulin sensitivity. It can be found in forms such as magnesium citrate [89, 90]. Coenzyme Q10 (CoQ10) lowers oxidative stress, increases cellular energy generation, and guards against cardiovascular disease. Due to its involvement in calcium metabolism, vitamin D enhances insulin sensitivity and boosts immunity; deficits are associated with metabolic dysfunction. In order to help with weight management, L-carnitine facilitates fat metabolism by delivering fatty acids into mitochondria [91, 92]. Psyllium husk and other fiber supplements help people lose weight by promoting satiety, controlling blood sugar, and enhancing intestinal health [93]. Because it contains epigallocatechin gallate (EGCG), green tea extract promotes weight loss, increases fat oxidation, and improves insulin sensitivity [94]. The antioxidant and anti-inflammatory properties of resveratrol, which is present in grapes, enhance insulin sensitivity and endothelial function [95]. Because it contains sulfur and allicin components, garlic extract helps people lose weight, improve their cholesterol, and lower their blood pressure [96]. Finally, by regulating cortisol levels, decreasing stress-induced fat storage, and improving insulin sensitivity, the adaptogen ashwagandha promotes overall metabolic health and aids in stress management [97].

    The potential of Saccharomyces boulardii to enhance gut health and decrease inflammation—two major contributors to metabolic dysfunction—has made it a viable novel supplement in the treatment of metabolic syndrome [98]. It has been demonstrated that this probiotic yeast alters the GM, improving the ratio of good bacteria to bad bacteria and decreasing the number of harmful microorganisms. This may help mitigate some of the systemic problems linked to metabolic syndrome, including obesity and insulin resistance. In addition to improving intestinal permeability and reducing signs of chronic low-grade inflammation, a characteristic of metabolic syndrome, S. boulardii’ anti-inflammatory qualities may also limit the transfer of toxins that could worsen metabolic abnormalities [99, 100]. Moreover, studies indicate that S. boulardii may contribute to liver function support, blood glucose reduction, and improved lipid profiles. Early research suggests that S. boulardii is a novel, supplemental supplement for those with metabolic syndrome, while additional research is needed to completely grasp its therapeutic potential [101, 102].

    Alongside dietary changes and postbiotics, innovative supplements are gaining popularity as adjuncts to managing metabolic syndrome. These supplements target specific aspects of metabolism, gut health, and inflammation, as shown in Table 3.

    Innovative supplements complement dietary changes to manage metabolic syndrome effectively

    SupplementKey ingredientsPotential benefitsMechanisms of actionReferences
    ProbioticsLactobacillus, Bifidobacterium, SaccharomycesImproves gut microbiome health, enhances insulin sensitivity, reduces inflammation, aids weight managementProbiotics restore GM balance, enhance SCFA production, and reduce systemic inflammation, which improves metabolic markers like blood sugar and lipid profiles.Dugoua et al. [103], 2009; Igbafe et al. [104], 2020; Yang et al. [105], 2022
    BerberineBerberine extract (from Berberis species)Improves insulin sensitivity, reduces blood sugar and lipids, supports weight lossBerberine activates AMP-activated protein kinase (AMPK), improving insulin sensitivity, glucose metabolism, and lipid regulation.Pirillo and Catapano [106], 2015; Xu et al. [107], 2021
    CurcuminCurcumin (from turmeric)Reduces inflammation, improves insulin sensitivity, supports liver healthCurcumin has potent anti-inflammatory effects, reduces oxidative stress, and modulates metabolic pathways linked to insulin resistance and fat metabolism.Shao et al. [108], 2012; Navekar et al. [109], 2017
    Omega-3 fatty acidsFish oil (EPA, DHA), algal oilReduces inflammation, improves blood lipids, supports cardiovascular healthOmega-3 fatty acids reduce systemic inflammation, lower triglycerides, improve HDL cholesterol, and enhance insulin sensitivity.Ellulu et al. [110], 2015; Santos et al. [111], 2020
    Alpha-lipoic acid (ALA)ALAImproves insulin sensitivity, reduces oxidative stress, supports weight managementALA acts as an antioxidant, reduces oxidative damage, enhances glucose uptake, and improves lipid metabolism, helping to reduce risk factors of metabolic syndrome.Najafi et al. [112], 2022
    Cinnamon extractCinnamon polyphenols (Cinnamomum cassia)Lowers blood sugar, improves insulin sensitivity, reduces inflammationCinnamon increases insulin receptor sensitivity and enhances glucose uptake in cells, contributing to better blood sugar control.Tangvarasittichai et al. [113], 2015; Mollazadeh and Hosseinzadeh [114], 2016; Shang et al. [115], 2021
    Chromium picolinateChromium (elemental form)Improves blood glucose regulation, enhances insulin sensitivityChromium plays a role in enhancing insulin action, improving glucose uptake, and stabilizing blood sugar levels.Zhao et al. [116], 2022
    MagnesiumMagnesium citrate, magnesium glycinateImproves insulin sensitivity, supports blood pressure regulation, aids sleepMagnesium helps regulate glucose metabolism, supports endothelial function, and improves insulin sensitivity, which is crucial for metabolic syndrome management.Cloyd [117], 2023; Fatima et al. [118], 2024
    Coenzyme Q10 (CoQ10)CoQ10 (ubiquinone)Supports mitochondrial function, reduces oxidative stress, improves heart healthCoQ10 boosts cellular energy production, reduces inflammation, and protects against oxidative damage, improving overall metabolic function and cardiovascular health.Gutierrez-Mariscal et al. [119], 2020; Ochoa et al. [120], 2005
    Vitamin DVitamin D3 (cholecalciferol)Improves insulin sensitivity, supports immune function, regulates blood pressureVitamin D plays a role in calcium metabolism, insulin sensitivity, and immune function, while deficiencies are linked to metabolic dysfunction and increased risk of diabetes.Garbossa and Folli [121], 2017; Szymczak-Pajor et al. [122], 2020
    L-CarnitineL-Carnitine (from animal or plant sources)Supports fat metabolism, improves exercise performance, aids in weight lossL-Carnitine transports fatty acids into mitochondria for energy production, aiding fat oxidation and helping with weight management.Prakash et al. [123], 2023
    Fiber supplementsPsyllium husk, inulin, glucomannanReduces blood sugar, improves gut health, supports weight lossFiber supplements improve gut motility, help regulate blood sugar levels, and promote satiety, which aids in weight loss and reduces risk factors for metabolic syndrome.Pokushalov et al. [124], 2024; Gamage et al. [125], 2018
    Green tea extractEGCGIncreases fat oxidation, improves insulin sensitivity, supports weight lossEGCG in green tea enhances thermogenesis and fat oxidation while also increasing insulin sensitivity, which aids in reducing body fat and improving metabolic health.Most et al. [126], 2016; Kapoor et al. [127], 2017
    ResveratrolResveratrol (from grapes, red wine)Reduces inflammation, improves insulin sensitivity, supports cardiovascular healthResveratrol acts as an antioxidant and anti-inflammatory, improving endothelial function, reducing oxidative stress, and enhancing insulin sensitivity.Castaldo et al. [128], 2019; Barber et al. [129], 2022
    Garlic extractAllicin, sulfur compoundsReduces blood pressure, improves cholesterol levels, supports weight lossGarlic extract possesses anti-inflammatory properties, reduces blood pressure, and enhances lipid profiles, thereby contributing to improved metabolic health.Salehi et al. [130], 2019; Piragine et al. [131], 2022
    AshwagandhaWithanolides (from Withania somnifera)Reduces stress, improves insulin sensitivity, supports weight managementAshwagandha modulates cortisol levels, reducing stress-related fat accumulation and inflammation while improving glucose metabolism and insulin sensitivity.Quinones et al. [132], 2025; Rakha et al. [133], 2023
    Display full size

    EGCG: epigallocatechin gallate; GM: gut microbiota; SCFA: short-chain fatty acid

    Probiotic and prebiotic supplements

    Supplements can be a valuable tool for individuals who cannot obtain sufficient probiotics and prebiotics from their diet. Probiotic supplements containing specific strains of beneficial bacteria have been shown to improve gut microbiome diversity, reduce inflammation, and enhance insulin sensitivity. Prebiotic supplements containing fibers like inulin and fructooligosaccharides can help promote the growth of beneficial bacteria and support the production of SCFAs. When combined, probiotics and prebiotics—often called synbiotics—offer synergistic benefits for metabolic health [83, 134].

    Omega-3 fatty acids

    Omega-3 supplements, derived from fish oil or algae, have been extensively studied for their anti-inflammatory and metabolic benefits. Omega-3 fatty acids have been shown to improve insulin sensitivity, lower triglyceride levels, and reduce inflammation—key factors in managing metabolic syndrome. Regular supplementation with omega-3 fatty acids can help restore balance to the gut microbiome and support overall metabolic health [135].

    Polyphenols and antioxidants

    Polyphenols, found in foods such as berries, green tea, and dark chocolate, are potent antioxidants that can help reduce oxidative stress and inflammation. Recent studies suggest that polyphenols may also have prebiotic-like effects, promoting the growth of beneficial gut bacteria. Supplements containing polyphenol-rich extracts, such as resveratrol and curcumin, may help improve insulin sensitivity and reduce the risk of developing metabolic syndrome [136].

    Berberine

    Berberine, a plant-derived compound, has garnered attention for its ability to improve insulin sensitivity, regulate blood sugar levels, and reduce cholesterol levels. Several studies have demonstrated its potential to combat metabolic syndrome by modulating gut microbiome composition and improving systemic inflammation. As a supplement, berberine has shown promise as a natural adjunct to conventional treatments for metabolic syndrome [137, 138].

    Gaps and future directions

    Despite the growing interest in the gut microbiome’s role in health, several limitations hinder progress, including the heterogeneity in microbiome studies and the reliance on animal models, which often fail to translate to human health outcomes directly. To overcome these challenges, future research should focus on human-based studies, greater standardization in methodologies, and the exploration of personalized nutrition that tailors dietary recommendations based on individual microbiome profiles. Additionally, long-term randomized controlled trials (RCTs) on the efficacy of postbiotics and other microbiome-targeted therapies, such as fecal microbiota transplantation, are needed to establish their lasting impact on health. While microbiome-related interventions, including dietary strategies and supplements, hold significant promise, it is essential to acknowledge the gaps in current evidence and avoid overstatements about their potential. Future clinical applications must be guided by robust clinical trials that address individual variation and assess long-term safety and effectiveness, ultimately leading to personalized therapies that integrate dietary strategies, supplements, and microbiome modulation to enhance health outcomes.

    Conclusions

    Metabolic syndrome is a complex and multifactorial disorder, but emerging research highlights the critical role of gut health in its prevention and management. Dietary strategies, postbiotics, and supplements may support metabolic health, though evidence gaps remain. By adopting a diet rich in fiber, fermented foods, and healthy fats, individuals can support a diverse and beneficial gut microbiome that is pivotal in regulating metabolism. Coupled with the use of postbiotics and supplements, such as probiotics, omega-3 fatty acids, and polyphenols, these dietary strategies offer a comprehensive approach to managing metabolic syndrome and enhancing long-term health outcomes. As we continue to uncover the intricate connections between the gut microbiome and metabolic health, these innovative interventions will become increasingly important in combating metabolic syndrome. Finally, clinical trials should guide personalized therapies, integrating diet, supplements, and microbiomes.

    Abbreviations

    ALA:

    alpha-lipoic acid

    CoQ10:

    coenzyme Q10

    EGCG:

    epigallocatechin gallate

    GM:

    gut microbiota

    NAFLD:

    non-alcoholic fatty liver disease

    SCFAs:

    short-chain fatty acids

    Declarations

    Author contributions

    SC: Conceptualization, Writing—original draft, Writing—review & editing, Supervision. VD: Conceptualization, Writing—original draft, Writing—review & editing, Investigation. AS: Conceptualization, Writing—original draft, Writing—review & editing, Investigation. RPP: Conceptualization, Writing—original draft, Writing—review & editing, Validation, Supervision.

    Conflicts of interest

    The authors declare that they have no conflicts of interest.

    Ethical approval

    Not applicable.

    Consent to participate

    Not applicable.

    Consent to publication

    Not applicable.

    Availability of data and materials

    Not applicable.

    Funding

    Not applicable.

    Copyright

    © The Author(s) 2025.

    Publisher’s note

    Open Exploration maintains a neutral stance on jurisdictional claims in published institutional affiliations and maps. All opinions expressed in this article are the personal views of the author(s) and do not represent the stance of the editorial team or the publisher.

    References

    Castro-Barquero S, Ruiz-León AM, Sierra-Pérez M, Estruch R, Casas R. Dietary Strategies for Metabolic Syndrome: A Comprehensive Review. Nutrients. 2020;12:2983. [DOI] [PubMed] [PMC]
    Andersen CJ, Fernandez ML. Dietary strategies to reduce metabolic syndrome. Rev Endocr Metab Disord. 2013;14:24154. [DOI] [PubMed]
    Croci S, D’Apolito LI, Gasperi V, Catani MV, Savini I. Dietary Strategies for Management of Metabolic Syndrome: Role of Gut Microbiota Metabolites. Nutrients. 2021;13:1389. [DOI] [PubMed] [PMC]
    Ambroselli D, Masciulli F, Romano E, Catanzaro G, Besharat ZM, Massari MC, et al. New Advances in Metabolic Syndrome, from Prevention to Treatment: The Role of Diet and Food. Nutrients. 2023;15:640. [DOI] [PubMed] [PMC]
    Marrone G, Guerriero C, Palazzetti D, Lido P, Marolla A, Di Daniele F, et al. Vegan Diet Health Benefits in Metabolic Syndrome. Nutrients. 2021;13:817. [DOI] [PubMed] [PMC]
    Mohamed SM, Shalaby MA, El-Shiekh RA, El-Banna HA, Emam SR, Bakr AF. Metabolic syndrome: risk factors, diagnosis, pathogenesis, and management with natural approaches. Food Chem Adv. 2023;3:100335. [DOI]
    Wang PX, Deng XR, Zhang CH, Yuan HJ. Gut microbiota and metabolic syndrome. Chin Med J (Engl). 2020;133:80816. [DOI] [PubMed] [PMC]
    Netto Candido TL, Bressan J, Alfenas RCG. Dysbiosis and metabolic endotoxemia induced by high-fat diet. Nutr Hosp. 2018;35:143240. [DOI] [PubMed]
    Alhabeeb H, AlFaiz A, Kutbi E, AlShahrani D, Alsuhail A, AlRajhi S, et al. Gut Hormones in Health and Obesity: The Upcoming Role of Short Chain Fatty Acids. Nutrients. 2021;13:481. [DOI] [PubMed] [PMC]
    O’Riordan KJ, Collins MK, Moloney GM, Knox EG, Aburto MR, Fülling C, et al. Short chain fatty acids: Microbial metabolites for gut-brain axis signalling. Mol Cell Endocrinol. 2022;546:111572. [DOI] [PubMed]
    Dabke K, Hendrick G, Devkota S. The gut microbiome and metabolic syndrome. J Clin Invest. 2019;129:40507. [DOI] [PubMed] [PMC]
    Mazidi M, Rezaie P, Kengne AP, Mobarhan MG, Ferns GA. Gut microbiome and metabolic syndrome. Diabetes Metab Syndr Clin Res Rev. 2016;10:S1507. [DOI]
    Yumuk V, Tsigos C, Fried M, Schindler K, Busetto L, Micic D, et al.; Obesity Management Task Force of the European Association for the Study of Obesity. European Guidelines for Obesity Management in Adults. Obes Facts. 2015;8:40224. [DOI] [PubMed] [PMC]
    Yaghmaei H, Bahanesteh A, Soltanipur M, Takaloo S, Rezaei M, Siadat SD. The Role of Gut Microbiota Modification in Nonalcoholic Fatty Liver Disease Treatment Strategies. Int J Hepatol. 2024;2024:4183880. [DOI] [PubMed] [PMC]
    Dong K, Zheng Y, Wang Y, Guo Q. Predictive role of neutrophil percentage-to-albumin ratio, neutrophil-to-lymphocyte ratio, and systemic immune-inflammation index for mortality in patients with MASLD. Sci Rep. 2024;14:30403. [DOI]
    Festi D, Schiumerini R, Eusebi LH, Marasco G, Taddia M, Colecchia A. Gut microbiota and metabolic syndrome. World J Gastroenterol. 2014;20:1607994. [DOI] [PubMed] [PMC]
    Alou MT, Lagier JC, Raoult D. Diet influence on the gut microbiota and dysbiosis related to nutritional disorders. Hum Microbiome J. 2016;1:311. [DOI]
    Amabebe E, Robert FO, Agbalalah T, Orubu ESF. Microbial dysbiosis-induced obesity: role of gut microbiota in homoeostasis of energy metabolism. Br J Nutr. 2020;123:112737. [DOI] [PubMed]
    Saad MJ, Santos A, Prada PO. Linking Gut Microbiota and Inflammation to Obesity and Insulin Resistance. Physiology (Bethesda). 2016;31:28393. [DOI] [PubMed]
    Visekruna A, Luu M. The Role of Short-Chain Fatty Acids and Bile Acids in Intestinal and Liver Function, Inflammation, and Carcinogenesis. Front Cell Dev Biol. 2021;9:703218. [DOI] [PubMed] [PMC]
    Mozaffarian D, Wu JHY. Flavonoids, Dairy Foods, and Cardiovascular and Metabolic Health: A Review of Emerging Biologic Pathways. Circ Res. 2018;122:36984. [DOI] [PubMed] [PMC]
    Schoeler M, Caesar R. Dietary lipids, gut microbiota and lipid metabolism. Rev Endocr Metab Disord. 2019;20:46172. [DOI] [PubMed] [PMC]
    Wang K, Yu X, Li Y, Guo Y, Ge L, Pu F, et al. Bifidobacterium bifidum TMC3115 Can Characteristically Influence Glucose and Lipid Profile and Intestinal Microbiota in the Middle-Aged and Elderly. Probiotics Antimicrob Proteins. 2019;11:118294. [DOI] [PubMed]
    Zarezadeh M, Musazadeh V, Faghfouri AH, Roshanravan N, Dehghan P. Probiotics act as a potent intervention in improving lipid profile: An umbrella systematic review and meta-analysis. Crit Rev Food Sci Nutr. 2023;63:14558. [DOI] [PubMed]
    Candelli M, Franza L, Pignataro G, Ojetti V, Covino M, Piccioni A, et al. Interaction between Lipopolysaccharide and Gut Microbiota in Inflammatory Bowel Diseases. Int J Mol Sci. 2021;22:6242. [DOI] [PubMed] [PMC]
    Saltzman ET, Palacios T, Thomsen M, Vitetta L. Intestinal Microbiome Shifts, Dysbiosis, Inflammation, and Non-alcoholic Fatty Liver Disease. Front Microbiol. 2018;9:61. [DOI] [PubMed] [PMC]
    Çakirlar FK. Microbiota and Metabolic Syndrome. In: Metabolic Syndrome: A Comprehensive Update with New Insights. Bentham Science Publishers; 2025. pp. 295–327. [DOI]
    Han H, Yi B, Zhong R, Wang M, Zhang S, Ma J, et al. From gut microbiota to host appetite: gut microbiota-derived metabolites as key regulators. Microbiome. 2021;9:162. [DOI] [PubMed] [PMC]
    Smitka K, Prochazkova P, Roubalova R, Dvorak J, Papezova H, Hill M, et al. Current Aspects of the Role of Autoantibodies Directed Against Appetite-Regulating Hormones and the Gut Microbiome in Eating Disorders. Front Endocrinol (Lausanne). 2021;12:613983. [DOI] [PubMed] [PMC]
    Koh A, De Vadder F, Kovatcheva-Datchary P, Bäckhed F. From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites. Cell. 2016;165:133245. [DOI] [PubMed]
    Portincasa P, Bonfrate L, Vacca M, De Angelis M, Farella I, Lanza E, et al. Gut Microbiota and Short Chain Fatty Acids: Implications in Glucose Homeostasis. Int J Mol Sci. 2022;23:1105. [DOI] [PubMed] [PMC]
    Chávez-Talavera O, Tailleux A, Lefebvre P, Staels B. Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease. Gastroenterology. 2017;152:167994.e3. [DOI] [PubMed]
    Ramírez-Pérez O, Cruz-Ramón V, Chinchilla-López P, Méndez-Sánchez N. The Role of the Gut Microbiota in Bile Acid Metabolism. Ann Hepatol. 2017;16:s1520. [DOI] [PubMed]
    Aron-Wisnewsky J, Warmbrunn MV, Nieuwdorp M, Clément K. Metabolism and Metabolic Disorders and the Microbiome: The Intestinal Microbiota Associated With Obesity, Lipid Metabolism, and Metabolic Health-Pathophysiology and Therapeutic Strategies. Gastroenterology. 2021;160:57399. [DOI] [PubMed]
    Vallianou N, Stratigou T, Christodoulatos GS, Dalamaga M. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Obesity and Obesity-Associated Metabolic Disorders: Current Evidence and Perspectives. Curr Obes Rep. 2019;8:31732. [DOI] [PubMed]
    Hayyat FS, Allayie SA, Malik JA, Dar SA. The Role of Dietary Fiber in Promoting Health: A Review of Choice and Outcomes. In: Malik JA, Goyal MR, Kumari A, editors. Food Process Engineering and Technology. Singapore: Springer; 2024. pp. 493–508. [DOI]
    Obayomi OV, Olaniran AF, Owa SO. Unveiling the role of functional foods with emphasis on prebiotics and probiotics in human health: A review. J Funct Foods. 2024;119:106337. [DOI]
    Saidaiah P, Banu Z, Khan AA, Geetha A, Somraj B. A comprehensive review of Omega-3 fatty acids: Sources, industrial applications, and health benefits. Ann Phytomedicine. 2024;13:20925. [DOI]
    Miclotte L, Van de Wiele T. Food processing, gut microbiota and the globesity problem. Crit Rev Food Sci Nutr. 2020;60:176982. [DOI] [PubMed]
    Hever J, Cronise RJ. Plant-based nutrition for healthcare professionals: implementing diet as a primary modality in the prevention and treatment of chronic disease. J Geriatr Cardiol. 2017;14:35568. [DOI] [PubMed] [PMC]
    Sharma A, Yadav BS, Ritika. Resistant starch: physiological roles and food applications. Food Rev Int. 2008;24:193234. [DOI]
    Ahajumobi NE. Nutrients, Vitamins, Mineral and Hydration for Health Restoration. iUniverse; 2022.
    Stengler M. The Holistic Guide to Gut Health: Discover the Truth About Leaky Gut, Balancing Your Microbiome, and Restoring Whole-Body Health. Hay House, Inc; 2024.
    Mirhosseini SM, Mahdavi A, Yarmohammadi H, Razavi A, Rezaei M, Soltanipur M, et al. What is the link between the dietary inflammatory index and the gut microbiome? A systematic review. Eur J Nutr. 2024;63:240719. [DOI]
    Zheng Y, Hou J, Guo S, Song J. The association between the dietary index for gut microbiota and metabolic dysfunction-associated fatty liver disease: a cross-sectional study. Diabetol Metab Syndr. 2025;17:17. [DOI]
    Zheng J, Hoffman KL, Chen JS, Shivappa N, Sood A, Browman GJ, et al. Dietary inflammatory potential in relation to the gut microbiome: results from a cross-sectional study. Br J Nutr. 2020;124:93142. [DOI]
    Lozano CP, Wilkens LR, Shvetsov YB, Maskarinec G, Park SY, Shepherd JA, et al. Associations of the Dietary Inflammatory Index with total adiposity and ectopic fat through the gut microbiota, LPS, and C-reactive protein in the Multiethnic Cohort–Adiposity Phenotype Study. Am J Clin Nutr. 2022;115:134456. [DOI]
    Tannock GW, Liu Y. Guided dietary fibre intake as a means of directing short-chain fatty acid production by the gut microbiota. J R Soc New Zeal. 2019;50:43455. [DOI]
    Vinelli V, Biscotti P, Martini D, Del Bo’ C, Marino M, Meroño T, et al. Effects of Dietary Fibers on Short-Chain Fatty Acids and Gut Microbiota Composition in Healthy Adults: A Systematic Review. Nutrients. 2022;14:2559. [DOI] [PubMed] [PMC]
    Fernández J, Redondo-Blanco S, Gutiérrez-del-Río I, Miguélez EM, Villar CJ, Lombo F. Colon microbiota fermentation of dietary prebiotics towards short-chain fatty acids and their roles as anti-inflammatory and antitumour agents: A review. J Funct Foods. 2016;25:51122. [DOI]
    Peredo-Lovillo A, Romero-Luna HE, Jiménez-Fernández M. Health promoting microbial metabolites produced by gut microbiota after prebiotics metabolism. Food Res Int. 2020;136:109473. [DOI] [PubMed]
    Beena Divya J, Kulangara Varsha K, Madhavan Nampoothiri K, Ismail B, Pandey A. Probiotic fermented foods for health benefits. Eng Life Sci. 2012;12:37790. [DOI]
    Parvez S, Malik KA, Ah Kang S, Kim HY. Probiotics and their fermented food products are beneficial for health. J Appl Microbiol. 2006;100:117185. [DOI] [PubMed]
    Dimidi E, Cox SR, Rossi M, Whelan K. Fermented Foods: Definitions and Characteristics, Impact on the Gut Microbiota and Effects on Gastrointestinal Health and Disease. Nutrients. 2019;11:1806. [DOI] [PubMed] [PMC]
    Dahiya D, Nigam PS. Probiotics, prebiotics, synbiotics, and fermented foods as potential biotics in nutrition improving health via microbiome-gut-brain axis. Fermentation. 2022;8:303. [DOI]
    Wang X, Qi Y, Zheng H. Dietary Polyphenol, Gut Microbiota, and Health Benefits. Antioxidants (Basel). 2022;11:1212. [DOI] [PubMed] [PMC]
    Barbalho SM, Goulart Rde A, Quesada K, Bechara MD, de Carvalho Ade C. Inflammatory bowel disease: can omega-3 fatty acids really help? Ann Gastroenterol. 2016;29:3743. [PubMed] [PMC]
    Garcia K, Ferreira G, Reis F, Viana S. Impact of dietary sugars on gut microbiota and metabolic health. Diabetology. 2022;3:54960. [DOI]
    Zhao J, Zhang X, Liu H, Brown MA, Qiao S. Dietary Protein and Gut Microbiota Composition and Function. Curr Protein Pept Sci. 2019;20:14554. [DOI] [PubMed]
    Ma N, Tian Y, Wu Y, Ma X. Contributions of the Interaction Between Dietary Protein and Gut Microbiota to Intestinal Health. Curr Protein Pept Sci. 2017;18:795808. [DOI] [PubMed]
    Bulsiewicz W. Fiber fueled: the plant-based gut health program for losing weight, restoring your health, and optimizing your microbiome. Penguin; 2020.
    Daniel IK, Njue OM, Sanad YM. Antimicrobial Effects of Plant-Based Supplements on Gut Microbial Diversity in Small Ruminants. Pathogens. 2023;13:31. [DOI] [PubMed] [PMC]
    Regassa A, Nyachoti CM. Application of resistant starch in swine and poultry diets with particular reference to gut health and function. Anim Nutr. 2018;4:30510. [DOI] [PubMed] [PMC]
    Keenan MJ, Zhou J, Hegsted M, Pelkman C, Durham HA, Coulon DB, et al. Role of resistant starch in improving gut health, adiposity, and insulin resistance. Adv Nutr. 2015;6:198205. [DOI] [PubMed] [PMC]
    Mach N, Fuster-Botella D. Endurance exercise and gut microbiota: A review. J Sport Health Sci. 2017;6:17997. [DOI] [PubMed] [PMC]
    Zhang L, Zhang Z, Xu L, Zhang X. Maintaining the Balance of Intestinal Flora through the Diet: Effective Prevention of Illness. Foods. 2021;10:2312. [DOI] [PubMed] [PMC]
    Bishehsari F, Magno E, Swanson G, Desai V, Voigt RM, Forsyth CB, et al. Alcohol and Gut-Derived Inflammation. Alcohol Res. 2017;38:16371. [PubMed] [PMC]
    Bajaj JS. Alcohol, liver disease and the gut microbiota. Nat Rev Gastroenterol Hepatol. 2019;16:23546. [DOI]
    Hills RD Jr, Pontefract BA, Mishcon HR, Black CA, Sutton SC, Theberge CR. Gut Microbiome: Profound Implications for Diet and Disease. Nutrients. 2019;11:1613. [DOI] [PubMed] [PMC]
    Ross FC, Patangia D, Grimaud G, Lavelle A, Dempsey EM, Ross RP, et al. The interplay between diet and the gut microbiome: implications for health and disease. Nat Rev Microbiol. 2024;22:67186. [DOI] [PubMed]
    Cooney OD, Nagareddy PR, Murphy AJ, Lee MKS. Healthy Gut, Healthy Bones: Targeting the Gut Microbiome to Promote Bone Health. Front Endocrinol (Lausanne). 2021;11:620466. [DOI] [PubMed] [PMC]
    Skinner E. The Bone Broth Miracle Diet: Lose Weight, Feel Great, and Revitalize Your Health in Just 21 Days. Simon and Schuster; 2017.
    Aleixandre A, Miguel M. Dietary fiber in the prevention and treatment of metabolic syndrome: a review. Crit Rev Food Sci Nutr. 2008;48:90512. [DOI] [PubMed]
    Deehan EC, Mocanu V, Madsen KL. Effects of dietary fibre on metabolic health and obesity. Nat Rev Gastroenterol Hepatol. 2024;21:30118. [DOI] [PubMed]
    Chan M, Larsen N, Baxter H, Jespersen L, Ekinci EI, Howell K. The impact of botanical fermented foods on metabolic syndrome and type 2 diabetes: a systematic review of randomised controlled trials. Nutr Res Rev. 2024;37:396415. [DOI] [PubMed]
    Şanlier N, Gökcen BB, Sezgin AC. Health benefits of fermented foods. Crit Rev Food Sci Nutr. 2019;59:50627. [DOI] [PubMed]
    Kim MJ, Kim JI, Ryu CH, Kang MJ. Effects of Fermented Beverage in Subjects with Metabolic Syndrome. Prev Nutr Food Sci. 2021;26:1220. [DOI] [PubMed] [PMC]
    Martínez Steele E, Juul F, Neri D, Rauber F, Monteiro CA. Dietary share of ultra-processed foods and metabolic syndrome in the US adult population. Prev Med. 2019;125:408. [DOI] [PubMed]
    Shu L, Zhang X, Zhou J, Zhu Q, Si C. Ultra-processed food consumption and increased risk of metabolic syndrome: a systematic review and meta-analysis of observational studies. Front Nutr. 2023;10:1211797. [DOI] [PubMed] [PMC]
    Ristic-Medic D, Vucic V. Dietary fats and metabolic syndrome. J Nutr Heal Food Sci. 2013;1:8.
    Tenorio-Jiménez C, Martínez-Ramírez MJ, Gil Á, Gómez-Llorente C. Effects of Probiotics on Metabolic Syndrome: A Systematic Review of Randomized Clinical Trials. Nutrients. 2020;12:124. [DOI] [PubMed] [PMC]
    Cani PD, Van Hul M. Novel opportunities for next-generation probiotics targeting metabolic syndrome. Curr Opin Biotechnol. 2015;32:217. [DOI] [PubMed]
    He M, Shi B. Gut microbiota as a potential target of metabolic syndrome: the role of probiotics and prebiotics. Cell Biosci. 2017;7:54. [DOI]
    Srivastava S, Kumar V, Kapil L, Prasad S, Kritika, Khan S, et al. Functional Foods and Spices in the Management of Metabolic Syndrome. In: Nutraceuticals in Obesity Management and Control. 1st Edition. Apple Academic Press; 2025. pp. 211–83.
    Jael Teresa de Jesús QV, Gálvez-Ruíz JC, Márquez Ibarra AA, Leyva-Peralta MA. Perspectives on Berberine and the Regulation of Gut Microbiota: As an Anti-Inflammatory Agent. Pharmaceuticals (Basel). 2025;18:193. [DOI] [PubMed] [PMC]
    Shehzad A, Ha T, Subhan F, Lee YS. New mechanisms and the anti-inflammatory role of curcumin in obesity and obesity-related metabolic diseases. Eur J Nutr. 2011;50:15161. [DOI] [PubMed]
    Innes JK, Calder PC. Marine omega-3 (N-3) fatty acids for cardiovascular health: an update for 2020. Int J Mol Sci. 2020;21:1362. [DOI] [PubMed] [PMC]
    Anderson RA, Zhan Z, Luo R, Guo X, Guo Q, Zhou J, et al. Cinnamon extract lowers glucose, insulin and cholesterol in people with elevated serum glucose. J Tradit Complement Med. 2015;6:3326. [DOI] [PubMed] [PMC]
    Havel PJ. A scientific review: the role of chromium in insulin resistance. Diabetes Educ. 2004;Suppl:214. [PubMed]
    Feng J, Wang H, Jing Z, Wang Y, Cheng Y, Wang W, et al. Role of Magnesium in Type 2 Diabetes Mellitus. Biol Trace Elem Res. 2020;196:7485. [DOI] [PubMed]
    Zozina VI, Covantev S, Goroshko OA, Krasnykh LM, Kukes VG. Coenzyme Q10 in Cardiovascular and Metabolic Diseases: Current State of the Problem. Curr Cardiol Rev. 2018;14:16474. [DOI] [PubMed] [PMC]
    Ulinski T, Cirulli M, Virmani MA. The role of L-carnitine in kidney disease and related metabolic dysfunctions. Kidney Dial. 2023;3:17891. [DOI]
    Kang DH, Jung EY, Chang UJ, Bae SH, Suh HJ. Psyllium husk combined with hydroxycitrate reduces body weight gain and body fat in diet-induced obese rats. Nutr Res. 2007;27:34955. [DOI] [PubMed]
    Jang HJ, Ridgeway SD, Kim JA. Effects of the green tea polyphenol epigallocatechin-3-gallate on high-fat diet-induced insulin resistance and endothelial dysfunction. Am J Physiol Endocrinol Metab. 2013;305:E144451. [DOI] [PubMed] [PMC]
    Parsamanesh N, Asghari A, Sardari S, Tasbandi A, Jamialahmadi T, Xu S, et al. Resveratrol and endothelial function: A literature review. Pharmacol Res. 2021;170:105725. [DOI] [PubMed]
    Ried K, Fakler P. Potential of garlic (Allium sativum) in lowering high blood pressure: mechanisms of action and clinical relevance. Integr Blood Press Control. 2014;7:7182. [DOI] [PubMed] [PMC]
    Winston D, Maimes S. Adaptogens: herbs for strength, stamina, and stress relief. Simon and Schuster; 2019.
    Egea MB, Oliveira Filho JG, Lemes AC. Investigating the Efficacy of Saccharomyces boulardii in Metabolic Syndrome Treatment: A Narrative Review of What Is Known So Far. Int J Mol Sci. 2023;24:12015. [DOI] [PubMed] [PMC]
    Cristofori F, Dargenio VN, Dargenio C, Miniello VL, Barone M, Francavilla R. Anti-Inflammatory and Immunomodulatory Effects of Probiotics in Gut Inflammation: A Door to the Body. Front Immunol. 2021;12:578386. [DOI] [PubMed] [PMC]
    Jantzi S. The Effects of Saccharomyces Cerevisiae Boulardii CNCM I-1079 Supplementation on Gut Barrier Function and Systemic Inflammation in Transition Dairy Cows [dissertation]. University of Guelph; 2024.
    Kothari D, Patel S, Kim SK. Probiotic supplements might not be universally-effective and safe: A review. Biomed Pharmacother. 2019;111:53747. [DOI] [PubMed]
    Yang W, Si SC, Wang WH, Li J, Ma YX, Zhao H, et al. Gut dysbiosis in primary sarcopenia: potential mechanisms and implications for novel microbiome-based therapeutic strategies. Front Microbiol. 2025;16:1526764. [DOI] [PubMed] [PMC]
    Dugoua JJ, Machado M, Zhu X, Chen X, Koren G, Einarson TR. Probiotic safety in pregnancy: a systematic review and meta-analysis of randomized controlled trials of Lactobacillus, Bifidobacterium, and Saccharomyces spp. J Obstet Gynaecol Can. 2009;31:54252. [DOI] [PubMed]
    Igbafe J, Kilonzo-Nthenge A, Nahashon SN, Mafiz AI, Nzomo M. Probiotics and antimicrobial effect of Lactiplantibacillus plantarum, Saccharomyces cerevisiae, and Bifidobacterium longum against common foodborne pathogens in poultry. Agriculture. 2020;10:368. [DOI]
    Yang F, Zhu WJ, Edirisuriya P, Ai Q, Nie K, Ji XM, et al. Beneficial effects of a combination of Clostridium cochlearium and Lactobacillus acidophilus on body weight gain, insulin sensitivity, and gut microbiota in high-fat diet--induced obese mice. Nutrition. 2022;93:111439. [DOI]
    Pirillo A, Catapano AL. Berberine, a plant alkaloid with lipid- and glucose-lowering properties: From in vitro evidence to clinical studies. Atherosclerosis. 2015;243:44961. [DOI] [PubMed]
    Xu X, Yi H, Wu J, Kuang T, Zhang J, Li Q, et al. Therapeutic effect of berberine on metabolic diseases: Both pharmacological data and clinical evidence. Biomed Pharmacother. 2021;133:110984. [DOI] [PubMed]
    Shao W, Yu Z, Chiang Y, Yang Y, Chai T, Foltz W, et al. Curcumin prevents high fat diet induced insulin resistance and obesity via attenuating lipogenesis in liver and inflammatory pathway in adipocytes. PLoS One. 2012;7:e28784. [DOI] [PubMed] [PMC]
    Navekar R, Rafraf M, Ghaffari A, Asghari-Jafarabadi M, Khoshbaten M. Turmeric Supplementation Improves Serum Glucose Indices and Leptin Levels in Patients with Nonalcoholic Fatty Liver Diseases. J Am Coll Nutr. 2017;36:2617. [DOI] [PubMed]
    Ellulu MS, Khaza’ai H, Abed Y, Rahmat A, Ismail P, Ranneh Y. Role of fish oil in human health and possible mechanism to reduce the inflammation. Inflammopharmacology. 2015;23:7989. [DOI] [PubMed]
    Santos HO, Price JC, Bueno AA. Beyond Fish Oil Supplementation: The Effects of Alternative Plant Sources of Omega-3 Polyunsaturated Fatty Acids upon Lipid Indexes and Cardiometabolic Biomarkers-An Overview. Nutrients. 2020;12:3159. [DOI] [PubMed] [PMC]
    Najafi N, Mehri S, Ghasemzadeh Rahbardar M, Hosseinzadeh H. Effects of alpha lipoic acid on metabolic syndrome: A comprehensive review. Phytother Res. 2022;36:230023. [DOI] [PubMed]
    Tangvarasittichai S, Sanguanwong S, Sengsuk C, Tangvarasittichai O. Effect of cinnamon supplementation on oxidative stress, inflammation and insulin resistance in patients with type 2 diabetes mellitus. Int J Toxicol Pharmacol Res. 2015;7.
    Mollazadeh H, Hosseinzadeh H. Cinnamon effects on metabolic syndrome: a review based on its mechanisms. Iran J Basic Med Sci. 2016;19:125870. [DOI] [PubMed] [PMC]
    Shang C, Lin H, Fang X, Wang Y, Jiang Z, Qu Y, et al. Beneficial effects of cinnamon and its extracts in the management of cardiovascular diseases and diabetes. Food Funct. 2021;12:12194220. [DOI]
    Zhao F, Pan D, Wang N, Xia H, Zhang H, Wang S, et al. Effect of Chromium Supplementation on Blood Glucose and Lipid Levels in Patients with Type 2 Diabetes Mellitus: a Systematic Review and Meta-analysis. Biol Trace Elem Res. 2022;200:51625. [DOI] [PubMed]
    Cloyd J. The top 6 essential health benefits of magnesium that you should know. Nutrition. 2023.
    Fatima G, Dzupina A, B Alhmadi H, Magomedova A, Siddiqui Z, Mehdi A, et al. Magnesium Matters: A Comprehensive Review of Its Vital Role in Health and Diseases. Cureus. 2024;16:e71392. [DOI] [PubMed] [PMC]
    Gutierrez-Mariscal FM, Arenas-de Larriva AP, Limia-Perez L, Romero-Cabrera JL, Yubero-Serrano EM, López-Miranda J. Coenzyme Q10 Supplementation for the Reduction of Oxidative Stress: Clinical Implications in the Treatment of Chronic Diseases. Int J Mol Sci. 2020;21:7870. [DOI] [PubMed] [PMC]
    Ochoa JJ, Quiles JL, Huertas JR, Mataix J. Coenzyme Q10 protects from aging-related oxidative stress and improves mitochondrial function in heart of rats fed a polyunsaturated fatty acid (PUFA)-rich diet. J Gerontol A Biol Sci Med Sci. 2005;60:9705. [DOI] [PubMed]
    Garbossa SG, Folli F. Vitamin D, sub-inflammation and insulin resistance. A window on a potential role for the interaction between bone and glucose metabolism. Rev Endocr Metab Disord. 2017;18:24358. [DOI] [PubMed]
    Szymczak-Pajor I, Drzewoski J, Śliwińska A. The Molecular Mechanisms by Which Vitamin D Prevents Insulin Resistance and Associated Disorders. Int J Mol Sci. 2020;21:6644. [DOI] [PubMed] [PMC]
    Prakash N, Ghosal S, Maity M. A Review on Therapeutic Effects of L-Carnitine: An Update. J Adv Zool. 2023;44.
    Pokushalov E, Ponomarenko A, Garcia C, Pak I, Shrainer E, Seryakova M, et al. The Impact of Glucomannan, Inulin, and Psyllium Supplementation (SolowaysTM) on Weight Loss in Adults with FTO, LEP, LEPR, and MC4R Polymorphisms: A Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients. 2024;16:557. [DOI] [PubMed] [PMC]
    Gamage HKAH, Tetu SG, Chong RWW, Bucio-Noble D, Rosewarne CP, Kautto L, et al. Fiber Supplements Derived From Sugarcane Stem, Wheat Dextrin and Psyllium Husk Have Different In Vitro Effects on the Human Gut Microbiota. Front Microbiol. 2018;9:1618. [DOI] [PubMed] [PMC]
    Most J, Timmers S, Warnke I, Jocken JWE, van Boekschoten M, de Groot P, et al. Combined epigallocatechin-3-gallate and resveratrol supplementation for 12 wk increases mitochondrial capacity and fat oxidation, but not insulin sensitivity, in obese humans: a randomized controlled trial. Am J Clin Nutr. 2016;104:21527. [DOI]
    Kapoor MP, Sugita M, Fukuzawa Y, Okubo T. Physiological effects of epigallocatechin-3-gallate (EGCG) on energy expenditure for prospective fat oxidation in humans: A systematic review and meta-analysis. J Nutr Biochem. 2017;43:110. [DOI] [PubMed]
    Castaldo L, Narváez A, Izzo L, Graziani G, Gaspari A, Minno GD, et al. Red Wine Consumption and Cardiovascular Health. Molecules. 2019;24:3626. [DOI] [PubMed] [PMC]
    Barber TM, Kabisch S, Randeva HS, Pfeiffer AFH, Weickert MO. Implications of Resveratrol in Obesity and Insulin Resistance: A State-of-the-Art Review. Nutrients. 2022;14:2870. [DOI] [PubMed] [PMC]
    Salehi B, Zucca P, Orhan IE, Azzini E, Adetunji CO, Mohammed SA, et al. Allicin and health: A comprehensive review. Trends Food Sci Technol. 2019;86:50216. [DOI]
    Piragine E, Citi V, Lawson K, Calderone V, Martelli A. Regulation of blood pressure by natural sulfur compounds: Focus on their mechanisms of action. Biochem Pharmacol. 2022;206:115302. [DOI]
    Quinones D, Barrow M, Seidler K. Investigating the Impact of Ashwagandha and Meditation on Stress Induced Obesogenic Eating Behaviours. J Am Nutr Assoc. 2025;44:6888. [DOI] [PubMed]
    Rakha A, Ramzan Z, Umar N, Rasheed H, Fatima A, Ahmed Z, et al. The Role of Ashwagandha in Metabolic Syndrome: A Review of Traditional Knowledge and Recent Research Findings. J Biol Regul Homeost. Agents. 2023;37:5091103. [DOI]
    Yoo JY, Kim SS. Probiotics and Prebiotics: Present Status and Future Perspectives on Metabolic Disorders. Nutrients. 2016;8:173. [DOI] [PubMed] [PMC]
    Jang H, Park K. Omega-3 and omega-6 polyunsaturated fatty acids and metabolic syndrome: A systematic review and meta-analysis. Clin Nutr. 2020;39:76573. [DOI] [PubMed]
    Chiva-Blanch G, Badimon L. Effects of Polyphenol Intake on Metabolic Syndrome: Current Evidences from Human Trials. Oxid Med Cell Longev. 2017;2017:5812401. [DOI] [PubMed] [PMC]
    Och A, Och M, Nowak R, Podgórska D, Podgórski R. Berberine, a Herbal Metabolite in the Metabolic Syndrome: The Risk Factors, Course, and Consequences of the Disease. Molecules. 2022;27:1351. [DOI] [PubMed] [PMC]
    Tabeshpour J, Imenshahidi M, Hosseinzadeh H. A review of the effects of Berberis vulgaris and its major component, berberine, in metabolic syndrome. Iran J Basic Med Sci. 2017;20:55768. [DOI] [PubMed] [PMC]